These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 16829539)
1. More is better with cardiac resynchronization therapy--but is it enough? Saxon LA Eur Heart J; 2006 Aug; 27(16):1891-2. PubMed ID: 16829539 [No Abstract] [Full Text] [Related]
2. Cardiac-resynchronization therapy in heart failure. Kirkorian GA N Engl J Med; 2005 Jul; 353(2):205-6; author reply 205-6. PubMed ID: 16014892 [No Abstract] [Full Text] [Related]
3. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224 [TBL] [Abstract][Full Text] [Related]
17. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter? Freedberg NA J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075 [No Abstract] [Full Text] [Related]
18. Cardiac resynchronization therapy for heart failure: has the time come? Yancy CW; Filardo G Circulation; 2009 Feb; 119(7):916-8. PubMed ID: 19237670 [No Abstract] [Full Text] [Related]
19. Cardiac resynchronization therapy in heart failure patients: an update. Jeevanantham V; Daubert JP; Zareba W Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393 [TBL] [Abstract][Full Text] [Related]
20. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]